This Week in Startups - E1 All-In with Chamath Palihapitiya & Jason Calacanis: US Response to COVID-19 & Impact on Startups, Venture Capital & Public Markets with David Friedberg
Episode Date: March 19, 20200:01 Jason & Chamath intro David and check in on each other's quarantines 2:26 Has the US overreacted or underreacted so far? David & Chamath give their opinions on new directives & statistics 13:15 T...houghts on potential treatment options & policy changes 22:25 Chamath explains the circumstances of recording a podcast while the Stock Market tanks in real-time 25:03 Should the US adopt Chinese & South Korean quarantine strategies? 29:53 What do the current market conditions mean for startups & VC? 41:24 Chamath explains what is currently happening in the capital markets 45:05 How close is the US on being able to do mass-testing? 54:13 Thoughts on bailouts for companies that manipulated their earnings-per-share ratio by stock buybacks? Impact on the global economy 1:03:14 Impact on luxury goods? Should there be a monthly stipend for low-income citizens? 1:12:10 COVID-19 exposing holes in the US healthcare system 1:17:44 Should we ban wet markets globally? 1:24:12 Over/Under: when Americans will be allowed to go out to restaurants again 1:28:18 When will the weekly poker game resume?
Transcript
Discussion (0)
All right, everybody, welcome to another edition of the All In Podcast.
We'll call this episode one.
We did a test and over 100,000 of you listened to the test podcast that we did the audio.
In a few days.
In a few days.
Chumath is already getting addicted to his statistics, a new podcaster.
I need to focus on something going up.
Yes, exactly.
Our portfolios are getting crushed, but the podcast numbers are going up.
A meaningless victory, to be sure.
but we got a lot of positive feedback and we're all sitting at home in quarantine.
As you can see, I set up my home office.
I got a microphone here.
And Shamath is in his bedroom.
And Dave Freerberg, I think, is in his wine room or something in his compound.
Are you in the safe room?
Is this the safe room?
Dave Freedberg is with us again.
He got a lot of great feedback and he's now on the Twitter.
You can follow him at Friedberg.
I don't know if he shut his Twitter down because he was getting harassed on Twitter.
Welcome to the club.
Are you in your safe room?
David? Yeah, it's brutal on Twitter. I don't know how you guys do it. You put something up and everyone, you know, just goes after you. It's harsh out there in the Twitter world, the Twitterverse. Basically, you have to mute and block anybody who is under 100 followers and being an absolute jerk because it's likely a Russian bot, you know, being run out of like Manila or something like that. They've got all these like sophisticated rings of people that they just hire for 10,
bucks a day to harass people online.
I mean, I know it sounds like a crazy conspiracy theory, but it's actually true.
There's large groups of bots who go after people and try to create chaos.
But hey, we're sitting here.
It's today's Wednesday.
We did our podcast on Saturday.
The stock market has gone down another 20% since then, I guess, or so.
And we are looking like this is going to be a 50% correction or something.
like that. We're now, you know, well past a 30 plus percent. And on the good news front,
it looks like testing is actually occurring and that work on a virus, work on treatments is
occurring. I don't know if we can call them cures, but treatments is occurring. And a quarantine
in place is being taken seriously. And I guess the biggest thing is that Trump has basically
admitted that this is a crisis and he's taking it seriously. Friedberg, what is your assessment
of where we are today versus when we taped on Saturday in terms of the resolution to this.
Are we overreacting, reacting just enough, or not reacting enough?
There's three things to consider.
The health, the policy, and then the markets.
On the health front, it seems like we have done a lot in terms of containment and we're
ramping up testing.
We are still not doing broad general population testing, which is necessary for us.
to truly understand the dynamics of this disease and also to understand the contagion of this disease.
And we need to fix that problem. There's a task force of 100 people out of D.C. being led by Jared Kushner
and a number of people from the tech industry that are working on ramping up testing and doing
broader general population testing. The policy decisions are what get quite scary. And that is all
of the containment, shutting down travel, shutting down borders, shutting down bridges and the economic
ramifications of doing so are frightening. I think I mentioned the other day that 48% roughly of the
U.S. workforce works in small businesses, another roughly 10% work in travel, another roughly 12%
work in energy. And you know, you kind of add this up and you can quickly see why
Steve Nuchin, the U.S. Treasury Secretary, was saying that we should expect 20 to 30% of the
workforce to be unemployed by this summer if we keep this up. So that is a frustrating and staggering
statistic and something worth debating whether that policy decision is appropriate relative
to the potential life and health and health system impact, you know, which one is worse.
And then the market question is just, I don't know how to address that, but things go
from that to worse, right?
Yeah, so let's start.
I have eight things that I want to cover.
Hold on.
Hold on.
Hold on.
We see one thing at a time here.
Everybody, everybody's warrant to go.
I want to say one more thing.
And it is, I think, the most important data to come out today.
So the markets are fucked.
We're all in trouble.
We're, you know, yada, yada.
The most scary thing is Ford and GM just shut down their plants today.
And the reason they shut down their plants is because out of fear of coronavirus and
auto workers, and the UAW basically force him to do it.
The world lives on a 30-day food supply.
So if you stop food production today, there would only be 30 days of food for the whole world
to eat based on our calorie consumption per day.
and especially with an isolated border and we import a lot of food in the United States.
If that means that we are then going to shut down other factories, the Ford GM shutdown,
and we're going to shut down food production, processing, and distribution factories,
then we have a food security crisis.
And this becomes a real societal problem.
So the concern that I have with the factories being shut down today is the precedent it sets
and the potential follow on from there in the food system.
And one thing we can't stop doing is making and distributing food to humans in the United States
or else we aren't going to have problems.
You're right, but before we go there, the good news is that these directives don't apply to national critical infrastructure.
And the food supply is covered within that.
So unless something cataclysmic happens, those folks are still going to make sure that food supply is there.
I do agree with you that the issue that we have to contend with is that, you know, there may not be as much.
and in the 30th to 90th day, that becomes a real issue of this thing becomes a very protracted problem.
This sort of brings us back, David, without being too alarmist about how we started and how you started really importantly at the beginning, which is there is a small but very credible body of evidence that is starting to show.
And this is what you put out on Twitter and part of why you got, you know, attacked probably by the pharma lobby.
but that shows that there is a, there is potentially an enormously large asymptomatic
spreader dynamic in this disease.
So can you describe that and what that may mean and why there's a lot of silver lining and
good news in that if it's true?
There are several data points that are showing us that there may be an unexpectedly high
number of people that get this disease and don't have any symptoms and show it.
The historical data that we've gathered to date has been largely symptomatic patients, and in some places like in Korea,
asymptomatic patients that had really close contact with symptomatic patients that were confirmed to be positive.
And in Korea, in particular, they found a large cohort, nearly 40% of the infected population were people between 20 and 29 years old that did not exhibit any symptoms or had very mild symptoms, had a runny nose, and didn't even know that they were sick.
On the Princess cruise ship, it turns out that up to 50% may have been asymptomatic.
People were all tested on that cruise ship because there were so many people that were positive.
And through that data set, that cohort, we found a very large asymptomatic population, 50% roughly.
The NBA players have now been tested, and out of seven players on five teams, so out of seven players on those five teams that have tested positive, it seems like none of them are having any symptoms.
There may be one person who's having a cough, but generally they seem one of, I think it was
Donovan Mitchell said I could go play a seven game series tomorrow.
So this data is really important, and it hasn't been fully accounted for in the models and
the predictions of the pandemic and the predictions of the fatality rate.
We're assuming that let's say 2% of people that get this disease end up dying.
And by the way, that's also based on an age histogram that may not be appropriate for our particular
cohort in the United States.
If you took that data and then you justed it based on the fact that a large percentage
of people actually don't die, but they end up just being asymptomatic, it really changes the
denominator and it skews the results. A paper published showed that in China, up to 86% of people
did not realize that they were sick or they were unreported and they had mild symptoms.
If you take that high level, you take that low level, call it somewhere between 25 and 86%,
maybe even as high as 86% of patients, are asymptomatic, which means that the actual fatality
rate is much, much lower, even in a large cohort that gets infected here. So we should be mindful of
this new data that's emerging, and we're still racing and acting from a policy basis as if 2% of
people, 3% of people, 4% of people that get this are going to die. And that may not actually
be true based on what we're seeing in the last week. I have a comment and a statement. The comment is
people will say, David, you can't extrapolate from an NBA player who may just be in peak physical
fitness, although I think your answer is going to be, it's not clear that the disease is
correlated necessarily with physical fitness for unphysical fitness at all.
It just may be the strain in how your body processes it.
But then the question is, doesn't this mean that we need to have broad-based, massive testing,
not just of symptomatic population, so not just the PCR test that we've heard a lot about,
but also these antibody tests so that we know that people have had it.
And what's the status of that, David?
What's the status of it?
That's exactly right, Chimot.
And by the way, on the healthy NBA player point, it's absolutely true.
People that are between 20 and 30, the average age of the NBA is 26 years old.
People that are between 20 and 30 years old generally seem to have no to mild symptoms based on what we saw in Korea.
The other data sets need to be taken into account.
So the NBA is an interesting anecdote, sure.
And you could discredit it all you want and say that it's a highly correlated
class and so on because everyone's together all the time.
But we could look at the data that came out of China in a paper that was published in the
journal Science and a paper that was published in the journal Nature from Korea that showed
very large percentages, anywhere from 20 to 50 to 80 percent or 90 percent of people being
completely asymptomatic across an age spectrum.
Certainly very heavier weighted towards the younger age bracket.
From children all the way up to 30 or 40 years old, you can be completely asymptomatic.
And so these are really interesting discoveries that have happened.
And so to your point, we need more data and we need to confirm that hypothesis because that's how science works.
So we have a hypothesis.
Let's go test it.
The problem is we're not testing it.
And we should be as a priority right now because the policy decisions we're making are based upon a denominator that may be wrong.
So the correct action should be to go get those antibody tests, go out into the population,
and start testing the asymptomatic general population and see what percentage of people in these high-risk zones like Seattle
and LA and New York and SF already have the antibodies to this virus, meaning they've been
infected with this virus and have not or are not showing any symptoms. And that gives us a better
sense of, A, how widespread this infection is, and B, the true dynamics of the fatality rate and
the symptomology of this disease and how it may affect people. Those IGG tests are being
made en masse in China today. They're being shipped to countries like Italy, where they are in fact
being used on the front line. They involve a blood draw, and then they have this lateral, it's
They're called a lateral flow assay in terms of how they're kind of tested.
The blood runs across a strip and you see a value, and you have a pretty good sense at that point.
Those kits cost a couple of pennies to make in China.
We could probably get a couple million of them.
I don't understand why we're not.
I don't understand why someone in the federal government isn't begging China and apologizing
and appeasing to them to send us those kits.
There are a lot of people I know that have bought them on the Internet.
I have a bunch of them.
People that I know have bought them.
They have been shipped in through brokers.
and they are not FDA approved.
They cannot be used for diagnostic purposes because of FDA guidelines and how the FDA regulates
these things.
They can be used for research purposes, but they may not be very sensitive and very specific,
and they don't have great testing on them.
So they estimate the sensitivity and the specificity to be 90%, roughly 10% false positive,
roughly 10% false negative.
But for what we're trying to accomplish, that's good enough.
We're not trying to give people a diagnosis of disease.
We're trying to run an epidemiological study, and we should, on the general population
to figure out how many people out there are asymptomatic and have been infected.
That is an important statistic that's missing.
And to your point, if we find out that there is a large population of people that have
actually felt this disease passed through them, it's faster that we can sort of get people
back to work out in the streets, which is now probably going to be the most important
thing we can do to just prevent a complete economic calamity.
Yeah.
Yeah. There are Jason.
And by the way, sorry, treatments, Jim, I'm sorry to interrupt you, but treatments are the other thing, and I think you're going to talk about that.
Treatments are interesting. Let's talk about that right now because to me what's incredible is again, now what is emerging.
And it's small and scale relative to how amplified it may should or should not be.
You know, remdesivir is very different, but it just seems like prophylactically even there's some data that show.
going out of France that chloroquine seems to be effective. These are these are solutions that are
pennies to make. And some of the some of the feedback that I've heard is that part of why the FDA,
the CDC, the federal apparatus is reluctant to embrace these things is in part because of
pressure from those lobbies. But that seems to me unfathomable in a moment like this. So why do you
think the government hasn't put out, the CDC has zero directive right now on the management and
efficacious management of this disease. Why is that? Okay, what Faiuchi and others have said,
and doctors around the country echo, is that these treatments have not been clinically tested
through a blinded, controlled study. And that is a very fair assertion, generally speaking,
for doing good medicine. But we are in a crisis state. And in a crisis state, you have to triage. And you
also have to triage policy. And we should be considering triaging policy and changing the way that
we do policy under these extenuating circumstances. If doing treatment can reduce fatality rates by up to
4x, as Korean doctors have claimed, it is worth taking the risk, or perhaps it is worth
letting the FDA say remdesivir, chaletra, chloroquine, and others are being widely produced,
widely distributed, the government is mandating it, and doctors and their patients can decide if
and when they want to use it and let them take the risk without clinical trials and without data
and the typical process of the FDA.
What's the downside of taking these drugs?
Are they particularly dangerous?
I mean, I've heard the colloquine, am I pronouncing correctly, coloquine?
I've heard that this can be a little bit nasty in terms of side effects.
So is there some major downside that, I mean, it's kind of like an off use of a drug, right?
Like this is an off use of a drug as opposed to...
It's an off use of a drug and some of the antivirals aren't even full.
tested in humans. So we don't yet know what the side effects may be. And also, remember,
side effects can change based upon your health condition. So someone that's in respiratory
distress may have different side effects than someone who's taking it in a healthy, controlled
clinical trial. So we're not really sure. That's the argument that doctors would make is, you know,
our first mandate is to do no harm. And so they don't want to apply a medicine that might do harm.
And so that is the standard protocol and practice and process. However, again, in a crisis state,
and Korea said, guys, we're trying this thing and it's working and we're adopting it.
Let's go for it. And they race forward. It could be that this is a good time for the United
States to consider an emergency policy action where we make a lot of this stuff, make it
available, and simply let doctors use their best judgment rather than have the FDA be the
paternal state that makes a decision for the doctors or makes a recommendation to the doctors.
What do we think the fatality rate actually is? Like, David, if you were looking at this and
you had to place a bet and put 100% of your net worth on it and be all in and have massive skin
in the game, where do you think the fatality rate here in the United States winds up being
overall?
Because the data that came out of Wuhan has been markedly going down as they get the numbers
corrected, who knows Chinese numbers, you know, censored by the government and maybe perhaps
massaged, it's going to be hard to tell.
What do you think the real fatality rate is?
The first fatality right I heard was 5.8% out of China.
The Wuhan data, based on the paper that came out in science over the weekend,
the Wuhan data was estimated to be 1.4%.
And Wuhan was the worst data out of China.
The quote-unquote rest of China is still estimated at about 0.15% or 0.16% or 0.14, something.
Something like that.
Versus like the flu every year or something or the normal flu.
1.1% roughly.
And so, you know, if you're looking at somewhere between 0.2 and 1.5,
percent. Now, in Italy, I think they're at over 7 percent. We talked about this on the last show,
but Italy is a much older population and their health system is completely overwhelmed.
So there's some confounding data. There's confounding variables there that may be making
Italy a very unique outlier on a distribution of what's going to happen here.
The United States has a population that's a little bit older than China, but much younger than
Italy. So our health system is, and our health system is generally more ICU beds per capita
than Italy, so we should be in a better place. The thing we don't know that does concern me about
the health system in the United States and the population of the United States is it seems that there
may be a high correlation with severity of disease and A1C levels. And as a result, the U.S. has one of the
highest obesity rates of any country in the world and highest diabetes rates. And so we may have a
population that has a very high percentage of people with a high A1C that may be at higher risk
than, say, people in other countries. I don't know that for sure. But,
those are two kind of confounding statistics that may kind of make things a little bit worse.
If I were to put my money on this, look, I'm a betting guy. I would be a little bit nervous at this
point, but I'd say it's probably somewhere between 0.15 and call it 1.8%. That's an order of
magnitude, I know. So, you know, but you could do the math. That's probably somewhere between
one and 10 times as bad as the flu. And so that, that again, leads to the big policy question about,
the actions warranted. Is it okay to let the health system crash? So that's a perfect then flip to you,
Chimoth. You've heard his, basically his line at, you know, 0.1 to 10 times the flu, 1.8 or something.
You know, if we split the difference of those two, it's 0.5, it's 0.6, 0.7 fatality rate.
Is the reaction of sheltering in place and the economic turmoil it's causing worth it?
Yes or no?
Right now, you guys need to keep talking.
need to jump off for two seconds and I'm going to come right back. I'll be right back.
Okay, no problem. And so what do you, what do you think now if we were to look at your estimate,
David, is it actually worth what's happening? Would we, if you and I were making the policy or
you and a Chamath were, you know, the cabinet members as it were making this decision,
is this decision and the economy crashing in a potentiality of 10, 15, 20 percent unemployment and
all the downstream effects, would it be better to do what the UK was originally doing, which
just said, hey, let's get the herd mentality going and let's get the herd immunity going.
I know this is like the most difficult question in the world, but we're here.
So let's...
Look, there's a spectrum of options.
It's not binary, right?
It may not be lock everyone up and let everyone out the door.
It may be that you have a more nuanced policy where you say, let's keep people over 65 years old,
give them the strong recommendation to stay home, and make sure that you distribute
chloroquine to doctors around the country.
So as soon as elderly people start having symptoms, they maybe get some.
treatment. But that's kind of an option. You keep 65-year-olds at home. You do random general
population antibody testing. And once you hit a certain percentage of the population, having been
exposed to this thing, it may be that at that point, you say, okay, you know, the over 65 limit is
lifted. Or it may be that, you know, you do something similar to that. Different age brackets have
different containment recommendations. You also do it with random genpops screening. You also do it
with medicine being distributed.
So there's a nuanced answer to that where the policy should be a little bit more directed.
It should be a little bit more involved in terms of treatment, testing, and containment strategy.
And it doesn't need to be so binary.
Right.
It doesn't have to be everybody stay at home.
If we get to the point where a population has very few people have had it, then more people
should stay home so it doesn't spread?
And then if more people have it, so if 50% of young people in San Francisco have it,
have it already, we've got herd immunity, then maybe we can start saying, hey, if you're over
65, you can go out, but just stay at a restaurant or something. Is that what you're saying?
Yeah, once you hit like 50 to 60 percent of the population having antibodies to a particular
virus, you, you know, or like a flu, for example, you'll see that R not number drop well below
one. And then basically-R-NOT to everybody again, just so we- Yeah, it's basically like the viral
coefficient. Like, for every one person that's infected, R-NOT tells you how many other people will
get infected after them. And so if it's 2.5, which is what some estimates say it is for coronavirus right now,
then for every one person that gets infected, roughly two and a half people get infected. And that number
goes down as more people get infected. Because as more people get infected, there's less people to infect,
and the rate at which you can then infect other people also drop so your R not collapses.
And so at a certain point, you have this kind of basis for saying, hey, guys, let's, again,
now I got to step off. Sorry, guys. You have no problem to do you think. So, Shumont, but David,
This is incredible.
I mean, what you were seeing in real time as we're doing this is literally like,
I've never seen this before.
We should probably explain what is going on.
So what is going on in the background is the markets are just completely torn.
Now, why are the markets important?
Many people aren't invested at all in the stock market.
I get it.
but it is where liquidity and capital markets function and derived out of those capital markets
is the money that then hits startups, it hits the banks, which then lend to small businesses.
It is the functional machine, the undergirding of the U.S. and the world economy.
And we are in a moment that I have really not seen since 2008 where there are seizures
in this market in extremely violent ways.
And so when I had to jump off the phone,
it was me trying to do my part to kind of help,
but also trying to make sure that we maintain full liquidity
in times like this.
It's incredible.
Now, Jason, on the assumption that Friedberg may or may not come back,
I mean, what dramatic podcasting we're dealing with.
I know. Well, you know, I mean, people also have their kids at home. So, you know, I might have to jump out and take care of the twins or my 10-year-old. So it is definitely having a psychological impact on everybody being home. You've been home for over two weeks. I've been home for a week. I went out once to do a podcast on my office with just one person there.
What I wanted to do was start at sort of the 10-foot level. And I'd like to build up to the 100,000 foot level. And I think that'll be a good way.
of talking about what we teased and talked about a little bit in episode zero,
which is sort of these second and third order dynamics.
Before we go to that, let me just, I want to wrap up with Dave would saying about
what the change in policy should or could be.
So right now we're having, you know, this basically quarantine.
In some cases, it's a hard quarantine.
In some cases, a little bit softer.
It's a recommendation.
And, you know, people are being told to, you know, stay,
home, should this change? And if, under what conditions do we start going back to normalcy?
Because I think that's what people want to know is when is this going to end and under what
circumstances? I'm just talking about, you know, staying home. Well, look, if it, if it were me,
I think what we would do is adopt some of the mitigation strategies of China and Korea and Singapore.
all of these countries have kind of showed us a way to deal with it.
Now, we have to decide that a short-term suspension of typical civil liberties
is worth the trade-off.
Now, it's not worth it under the normal course, under any, any imaginable way.
But if we had to trade off some of those civil liberties in the short course
so that we could get back to normalcy, I think most of us at this point,
and definitely all of us, after another week or two of home isolation,
will do it. And what I think it would entail is setting up zones that we would understand to be
uninfected. And what that means are people that don't have it or people that have antibodies
and eventually allowing those zones to reopen so that we can actually have some amount
of economic activity. And what that will require is massive testing of the entire population.
Testing, testing, testing.
I mean, there should be lines and lines and lines.
It should be, you know, how we would have, and we know, by the way, how to mobilize this.
It is no different than when we would go to vote.
Right.
And, you know, we could all be told based on birth year, right?
Everybody go based on birth year to your local voting facility.
There are phlebotomists there.
They can run these LFIAs.
They can, and they can allow you to be in a safe zone or not a safe zone.
If you're found to be an asymptomatic carrier, then you can self-quarantine and socially distance.
And we can really, you know, nip this thing in the bud in a, you know, four, five, six-week time frame.
And because these tests are available at such large scale and because these tests are so insignificantly cheap, if it were up to me, I would mobilize the military and the National Guard.
I would mobilize their voting infrastructure.
I mean, another way to do this would be, why don't we just have the National Guard or doctors or whatever,
just go to everybody's mailbox, put in the kits, and then say, you know, have your kit in here on this date, and we'll go pick up the kits.
The problem with these LFIAs is that the amount of blood that you need, you cannot draw by yourself.
It's not a finger.
What about the swab stuff?
I mean, if we just did the swab testing, we just said, hey, we're coming by your house.
The swab is a PCR test that's looking for RNA.
And the problem with that is that it's effective in a window.
it's uncomfortable to administer
and it has to be done right away
for those that are in the process of viral shedding.
If you are not in the process of viral shedding,
then that PCR test is effectively ineffective.
And what I'm advocating for is move past the PCR testing.
That should be done in an acute situation
if you come into a hospital where you're exhibiting symptoms.
The more important thing right now
is to find people that don't have it
or people who are asymptomatically spreading
or those people that are immune.
Because if we can re-baseline the denomination,
the denominator, as Friedberg said, we may find some good news in that it's very much like the
flu in terms of numerical distribution, in which case we can make some policy changes and
reestablish economic activity. If it turns out that it's not, at least we know that too.
But right now we're in the worst place, which is that we are in a situation of isolation and
confinement in the absence of data. And this is, I think, what's so infuriating to folks is that
we, you know, it's like Winston Churchill said,
America will do the right thing.
It's just that they'll try everything else first.
And I think that we are clearly on that path
to trying everything until we do the right thing.
Everything okay, Freeberg?
And I think it's political, I think it's political poker
as the reason why.
Freeberg, everything okay?
Just market trades.
Really?
He's like literally, you're trying to cover stuff and just
I'll tell you, it's a great time to tax harvest losses, man.
Yeah.
If you've got companies that you're really religious about that you would love to own for a long time and you're underwater on them,
it's a great time to sell them, take the loss, harvest it, and then buy them back in the next 30 days.
So, David, I have a list of eight things.
And what I told Jason is I wanted to start at the 10-foot level and end at the 100,000-foot level.
Okay.
And so I'm going to tee up the first question for both of you guys.
and I have a view, but I'll save it to the end.
So question number one of these eight lists of interesting things to talk about,
which may be relevant for the folks listening,
what does this mean for startups?
And what should you do if you are a unprofitable,
well, I mean, by definition, these companies are default dead.
What do you do if you're a startup CEO today?
Yeah, I think it's a great question.
I'm dealing with it, like with about a,
dozen companies a day who are in this very acute situation, you have to figure out,
you have to look at the instrument panel and then try to, like a pilot, I use the analogy,
understand exactly how much altitude you have, where the nearest airport is, how much fuel
you've got on board. So I literally told folks, listen, if you can close this money,
because a lot of people were in the middle of doing deals, close it immediately. So that's number
one. If you've got a deal on the table, take the money. And some people do, but most people don't.
And I'm already seeing people retrading deal terms based and backing out.
So I had one person back out of a deal on the syndicate.com.
And angel investors said, because of market conditions, I'm backing out.
And they had made the commitment.
They're backing out.
So you can see commitments broken.
So assume it's going to, that no money is going to get raised for the next three or six months at a minimum.
And then you have to ask yourself, well, how do I keep this company alive?
I have people who are founders taking 80% salary cuts and then giving their staff 50% salary cuts.
and then that takes their six months of runway, makes it nine.
So that's number one.
You have to just make the cuts.
And if you've chosen to be the founder of the company,
that's your job is to get everybody to safety.
And better to have four out of five or three out of five employees lose their job
and the company be alive to come back and maybe get some stimulus later
than to have the company go out of business because you wouldn't make the cuts.
So you've got to just take the medicine.
And that's really with first-time entrepreneurs, they don't understand that.
and if they have
every business is different.
We have some companies
that are subscription-based business
or delivery-based businesses
they're actually seeing
an increase in utilization
increase of people
trialing their software.
So I have one company
that's a consumer subscription
and they had more trials
this week than ever
because people have free time.
So that company is going to be fine
but you got to make the cuts.
David,
I'm not sure what your advice is
or what you're doing in your portfolio.
Yeah, I mean, look,
I'm on 12 boards.
Four companies have been or are in
the middle of term sheet or closing a deal. So it's been an unfortunate timing for all this stuff.
What happens to those four companies? Do you think they close the term sheets? Yeah, very different things.
I mean, we've got one that I hope we close on Friday. We signed on Friday last Friday the final docs and
money's not in the bank account yet. I've got another one that's had a bunch of offers that got rescinded,
but they weren't like signed yet. It's just all over the place. And I think, you know, one thing that's
worth kind of paying attention to for every company is you've got to ask yourself, firstly,
the hard question of going into this and coming out of this era that we're kind of now entering
that is a very bleak and dark era economically, where is your customer going to be? And what is
your customer going to be doing? The customer model is changing overnight. If you're a company
that sold software into restaurants and restaurants are about to potentially go bankrupt
or suffer absolutely loss of revenue and get debt payments restructured,
they're not going to necessarily be rushing to spend more money each month
unless you can help them immediately save money.
If you're a company selling to consumers and you're selling to consumers
that are going to lose their jobs in the next three months or lending to consumers,
they're going to be losing their jobs in the next three months.
You've got to be asking yourself the question, what can I be doing with my business?
So you've got to start with your strategy question.
And you've got to make sure that you're you've got to think about where your
customer is going to be and how you can adjust your strategy as a result. The second thing I'd say
is, and I sent out a note to my CEOs, and I was like, guys, you got to cut your burn and then
you've got to cut your burn and then you've got to cut your burn if you've got burned. You've got to do
everything you can to give yourself the greatest chance of survival. And I think on the last all-in
podcast, Jason, you mentioned having 36 months of cash, that's ideal. But if you can get your cash to get
you to an 18-month runway... Yeah, 18 is my average. Yeah. 18 is my average.
I mean, you should be doing everything you can to number one, kind of give yourself that breathing room.
Even if that means trading milestones, trading features, trading revenue goals, trading all the things that you're expecting to do, survival matters more than growth right now.
David Sinclair, who wrote the book Lifespan and is a Harvard biochemist, has highlighted that there's basically a gene, the surtee genes, there's about seven of them in humans.
And the surtee genes get turned on or off.
And it turns out every biological organism on planet Earth has a surtee gene.
The surtee gene tells the organism or tells the cell to either grow or heal.
And this is a time for everyone to activate their surtee genes.
And stop focusing on growth and focus on healing.
It's really important to optimize your unit economics, to make sure you know where your customer is,
to really reduce the burn, to reduce the spend, to reduce the push for growth and expansion,
and just make sure you've got a core business, that you have a customer, that you can make money from that customer,
that you've really got unit economics right
and reduce your burn and give yourself that runway
and extend your life.
So that's my kind of advice.
Well, I think we got question one out of the way.
Let me give you my advice,
which is building on the back of both of what you said.
But I'm going to take it from a different perspective.
So let's look inside of a VC firm.
VC firms have limited partners.
And those limited partners,
are the most sophisticated financial institutions in the world,
family offices of well-renowned individuals,
foundations, university endowments, nonprofits, you name it.
And all of them are allowed to invest in this asset class
because they themselves can prove that they're sophisticated.
And one way in which they do it is they have what's called portfolio allocation theory.
They construct a portfolio of every $100 they have and they say,
well, I'd like to have, you know, 70% of that in liquid instruments and that I'm going to have
60% in bonds and, you know, 40% in equities. And then that 30% they'll take and they'll say,
you know, I want to have a mixture of all kinds of different stuff, some real estate,
some hedge funds, some private equity. And eventually when all of those allocations are done,
there's an allocation to venture. Now, in the last few years, what happened is all of these folks,
you know, move the dial, they push the risk meter
so that the allocation into venture
was upwards of 7, 8, 9% of their overall portfolio.
Now, just to remind you guys,
you know, basic theory, monetary theory would tell you,
when you put money in into an e-liquid instrument,
remember venture doesn't return money until 13 years after it's done
and you can't get it out.
It's not like a bond where you can go
and instantaneously sell it in a second.
you have to get returns that are much better than the market
because you need to be rewarded, paid back for that illiquidity.
Now, in the last month, what you've seen are portfolios get completely turned upside down.
If your bonds and equities before were worth $60 or $70 of that $100,
it's now worth $56.
It could be worth $40.
What that means is that that other $30 needs to be worth much, much less.
Otherwise, your portfolio model is completely upside down, and all of these limited partners
become forced sellers as well.
So that can't happen.
So what is the – my understanding is the last time this happened in 2008, LPs kind of winked to the GPs and said,
listen, it would be good if there wasn't a capital call right now.
And then GPs not wanting to piss off their LPs, the VC firm's not wanting to piss off the endowments as an example, said, okay, we're just going to not make any capital calls right now while the market recovers so that your equities go up and the percentage of venture goes back down.
Is that the likely scenario?
Is LPs?
It's worse than that.
It's worse than that.
Because right now, these foundations and sovereign wealth funds are trying to just stay above water.
And as we get to the 10,000 and 100,000-foot view, I'll give you the picture of what's happening in their offices.
And again, it's important because it is what makes sure we come out of this reasonably well, which is a properly functioning capital market.
And right now, it is the most precarious that I have seen in 20 years.
So basically, these LPs are going to have to portfolio rebalance and they're going to have to force venture capitalists to mark down their books.
So wait, VCs are just going to make that decision to say, hey, my investment in Airbnb, Slack, or Uber is worth X now, I mean, when they were private companies.
Not Slack and not Uber because they're public.
Right.
No, but previously private, yeah.
But Airbnb, can it be marked at $30 or $40 billion?
The auditors will probably say no.
The LPs will say that it's not.
The GPs will want to because it'll allow them to maintain their IRAs, their rates of return.
And so what you're going to have is when these markdowns are forced to happen, which will take another six months, venture capitalists' returns will look terrible.
And so their propensity to be able to add bad dollars after good, quote unquote, you know, to defend every company is going to go to zero.
Right.
And as you said, Jason, there's going to be a pall on activity.
So I don't think 18 months is sufficient.
I think you need at least 36 months.
Double.
You need to have three years of capital in the bank.
The worst thing that will happen if you have 36 months is you think to yourself, wow, I was really conservative.
The best thing that happens with 36 months is you survive.
The distribution of outcomes would tell you there is zero point in taking the risk if you don't have to.
And this is why, unfortunately, it's going to be a very difficult,
process of recalibrating all of this stuff. So for folks that are in these startups,
we're going to have to go through an unfortunate period of pain. And, you know, as Buffett said,
you know, rule number one of our business is to not go out of business. Rule number two is not
to forget rule number one. Yeah. All right. I think it's well said. And is there any chance
while we're sort of at this, you know, street level on the front lines,
is there any chance that we contain this very quickly, let's say, under 60 days,
and that it looks like this virus mitigation through the various drugs we talked about
actually starts to work.
If that happens in the next 60 days, what will happen to the markets?
It's not what we're dealing with.
But Trump says there's a chance it could come,
roaring back. Where are the chances of a roar back?
It cannot come roaring back.
So let me explain to you what's happening right now in the capital market.
So let's take a step back and first look at what the Fed has announced over the last couple of days.
And here's why the Federal Reserve is important.
So the Fed basically acts as a market making and liquidity function in what's called the
overnight repo market.
Now, that's an obscure market for the average individual on Main Street.
but let me roughly explain why it exists.
And at the end of it, you're probably going to have the same reaction as me,
which is what the fuck fucking fuck.
Okay, but I'll explain it in English first.
You're an LP, a limited partner, and you give a hedge fund a dollar.
And very much like last episode, how I explained why hedge funds run levered,
the hedge fund says, well, if I take this dollar, you know,
the bank will give me some amount of leverage on it.
But it would be much better if I was able to basically give them an instrument like a bond or some sort of short-term commercial paper.
And then they'll give me more because they'll believe in the quality of the instrument.
Okay.
So they go in the repo market and they basically do a transaction overnight where they basically buy some short-term commercial paper.
They use it as collateral and then they lever it up and then they go put it in the market.
that entire dynamic works as long as the repo function works every day.
Every night you kind of go and you clean up your balance sheet,
you look at how much leverage you have,
you look at your leverage ratio,
you make sure that you have enough money,
and you go and you refinance your short-term paper
that keeps, you know, J.P. Morgan, Goldman Sachs, Morgan Stanley,
lending to you.
But if that market seizes, when the repo market seizes,
and there's no way for you to either buy or sell commercial paper,
buy or sell short-term money market instruments.
And on the other side, the markets are whipsying up and down.
And so you're being margin called, not being margin called, being margin called, being margin called.
The markets start to really seize and capitulate.
And everybody is just losing enormous amounts of money.
And what I mean by everybody, it's everybody.
It's hedge funds, it's sovereign wealth funds, it's foundations, it's central banks.
Everybody is losing money.
And if we don't figure out how to bring some calm into the financial markets,
it will leave all of these limited partners and all these other people
with not just a lack of liquidity and a lot less money than they had before,
but this psychological pain of remembering what they just went through.
And that'll prolong what we have to deal with to get.
out of it, right? So, you know, this is why I think it's really important to understand that
if we can nip the, you know, stage zero of this problem, which is the disease itself in the
bud, and I don't mean by curing it, and I don't mean with the vaccine, I mean by testing and
data. Yeah. If we can understand and bound it, then everybody's psychology can move to fixing
the capital markets. And right now, we need it to be fixed.
How close do you think we are to having that mass testing done?
And then I think we all think we're going to have a low mortality rate and then go back to normalcy.
Is that something that's happening in 10 days, 30 days, or 60 days if you had to pick a number?
The march back to normality.
David.
I don't see any action to get the testing done that needs to get done right now.
My mom got tested yesterday.
It seems like there are more tests out there this week than previously.
Stanford opened up the testing.
There's definitely PCR testing available now.
And you can probably get your results in three to four days on average,
although some labs are super backed up.
Yeah, my mom said she's going to take three days or four days.
Three days, yeah.
But the stuff that we're talking about,
which is the general population testing,
I'll keep saying it.
It's so critical that we do this to figure out how many people
have already been infected and didn't know it.
We don't have that data.
That we don't even have a plan for,
and it's not on the radar.
The task force in D.C. is focused right now
on increasing the throughput and the availability of PCR or just in time, you know,
PCR testing.
The blood testing.
Yeah, it's all blood testing.
It's just a matter of like, like, let me explain the PCR test involved, the RTPCR test
involves taking blood.
And then there's basically six steps that you have to go through with it in a lab.
And it's done on like three different machines.
And the actual cycle takes 30 to 60 minutes or 30 to 45 minutes.
So by the time you have that backlog.
And you can mold.
multiplex it, but meaning you can do multiple at the same time and you can kind of do different
things. But generally, these machines are not highly automated. There are new machines that are
allowing us to automate more of these steps and making them go a little bit faster and do more
multiplexing. But it is still a multi-step cycle to take the blood and turn it into a test
result once you've amplified the viral RNA and tried to measure its content. And so this takes
some time. And so it's a chemistry lab that's doing this work. So until we have,
have a point of care solution, which is like a test strip or something else.
And these are technically possible.
It's just that they're not FDA approved, and so they're not getting made and distributed
here, whereas China and Korea and Italy are using them out of, and they're made in factories
in China, even though they're not tested and approved in the normal way.
Isn't the plan, though, to have these untested tests online this week?
Isn't that what they're saying?
Yeah, a bunch of people are buying them.
Yeah.
But it, so I guess the question is, when do you think we will have,
these, you know, the general population taking tests.
And we get like a large-scale testing like South Korea did.
We all agree that's the part of the solution.
When does that happen?
Unfortunately, we're not parallel pathing it.
We've put all of our resources into increasing the availability and throughput of the RTPCR tests
for acute infection cases.
And as a result, we have everyone focused on this.
There was some lab work and some research departments, I won't name them, that we're
working on doing this general population testing.
but they got yanked into the getting the RTPCR scaled up because, oh my God, we're behind the curve.
We got to fix this thing.
So we got to get over this first hump.
I think once we get over this first hump, then you're going to see people distribute and work on this.
And I think getting over the first hump is happening in the next call it seven to ten days.
And so then it's probably another 30 to 45 days before we get these tests for general population
testing more broadly distributed.
So call it 45 days out.
Why can't we do this at the same time?
I mean, why can we parallel this?
It makes no sense to me where the greatest country.
We have so many scientists and so many entrepreneurs in Silicon Valley that are banging their head on the wall asking this question.
I've done so many phone calls over the last few days with people being like, what can we do?
How can we get these things made?
Where can we go?
And everyone's just like flustered.
It's really frustrating.
Anyway, we've got a lot of individuals that we're trying to kind of collect together to do this work.
Some folks are calling China today.
We're trying to see if we can get big bulk orders out of China.
We're just going to pay for it ourselves and then try and get some research labs to run the research universities around the country to run the experiments for us.
using these untested, unproven, you know, not-fee-approved tests.
Have you run one of these on yourself yet, one of these unproven tests yet?
I haven't.
I actually, a friend of ours, I did one with video on, with him this morning.
And so, you know, someone that we all know.
A mutual friend of ours.
Yeah.
And so, and then I know lots of people that have them and have used them.
And I've seen them and I've gone through, like, you know, I bought a bunch of them.
They arrived tomorrow.
And so I see, you know, we know how these things work.
They're actually from a reliable source, you know,
These are not, no one's actually done the testing to prove the specificity and sensitivity.
We're relying on a third party test, so we don't really know.
I keep hearing they're uncomfortable.
I keep hearing they're uncomfortable.
What's uncomfortable at them?
They stick it very far up your nose?
Is that what people are referring to?
Oh, no. You're referring to the RTPR test.
So what you're trying to do there is you're trying to get a sample of living virus on a swab.
And the best place to get that living virus for this particular virus is in your nose or in the back of your throat.
So they're taking a long cue tip and they're sticking it up your nose and they're sticking the back of your throat.
then they put it in a little solution that will keep the viral RNA alive,
and then that's what they're shipping to the lab,
and that's what then gets...
So it's uncomfortable to have it that far up your nose is what they're saying.
That's why people keep saying it's uncomfortable?
I've had more uncomfortable things up my nose.
I'm sure it's fine, you know.
Yeah.
It's a cue tip in your nose.
Yeah, it's a Q-tip way up in your nose.
Way up in your nose.
So we actually think that mass testing is a 30 to 60-day...
No, no, I think mass testing, if in the worst,
case is 30 to 60 days. What I'm imploring anybody with any influence is we need to get this
starting to happen in the next two to three weeks. It needs to start happening in the next two to three
weeks. And, you know, this is where I would say there are a lot of other people other than David,
myself, you, Jason, the people on our group chat buying tests for the mass population.
You know, I just want to say something here, which is it is incredible to see guys like Jack Ma step up and, you know, do what he can to send stuff here.
But I would say that thus far, there's largely been an inverse correlation of contribution and wealth during all of this.
And folks that are in a position to help, I think need to be more vocal.
You know, we all can't just participate when the times are good.
take advantage of the bully pulpit when the times are good.
And then when times are complicated, disappear and become anonymous.
It's part in why I think you and I decided to just do these as often as we can.
Yeah.
Because at least we can think through the problem so that at least people can hear our voices
and understand that we are thinking through as much as possible what to do.
I am literally calling folks in Wall Street all the time because what little I can do to assure them
or be a market participant right now to maintain liquidity,
I need to do,
because in the absence of that participation,
we're going to just create more and more havoc.
And I think it's important for other people
who are in a position either monetarily
or through influence or both to be out there right now
doing something.
You know, they should call Friedberg right now.
They should give Freedberg $100 million.
We'll go to China.
We'll get the test.
And we can do our own broad-based population study right now.
I would jump on that.
Right now, looking at the statistics as of today, we obviously the total cases in China hit 80,000 with 3,237 deaths.
They had only 11 new deaths yesterday.
And Italy, 35,000 total cases, 4,200 new cases.
And they added 475 deaths yesterday with a total death.
count of 2,978.
So that is just stunning what's happening in Italy.
And it seems, I don't know if the trendline is, it's getting worse or not.
But Italy is just overwhelmed.
It's a horrific and awful situation.
They're completely out of beds.
They're triaging elderly people and letting them die in the hall so that younger people
who have a higher chance of surviving can actually get oxygen.
It's just awful.
And they're having 3,500 new cases, or they're at 3,500.
Yeah, there are over 3,000 cases, but added yesterday.
So there is really, it is flattening, but who knows if that's because they're just overwhelmed
and they can't do the testing.
But the debts are something that seems to have gone down in the last three days.
We're looking at different time series.
The number of people that died yesterday are, in fact, the number of people that died
yesterday.
The number of people that tested positive yesterday doesn't tell you as much because the test
results may be four days delayed, and they may be 10 days into their symptoms by the time they
get tested, and so on and so forth. So the testing data significantly lags the infected population
count likely and may not represent much of anything, right? So it's very, and it's also hard to know
what the average fatality timeline looks like. There are published reports now out of China and Korea
that start to try and specify this a little bit, but we are looking at different time series when we
try and compare these things. And so everyone be cognizant of that as you look at these numbers. It's
not simple apples and apples. Let's move to a slightly second and third order, Jason. I think if
we stay in the disease, it's just going to be a fucking mental quagmire. We're going to jump up the
window. Yeah. Okay. Let's talk about something that Mark Cuban said, which I really agree with,
which is that if we're going to do bailouts, they can't come where we also do things like, you know,
allowing these companies to do buybacks where a CEO pay isn't curtailed. You know, it turns out that
the airline industry, which looks like is going to be first and
line for a bailout, spent 96 cents of every single dollar of free cash for they had on buying
back stock, which is only used to drive up earnings per share, which is only relevant for CEO
pay. So they have, you know, they don't have the cash buffer. They don't have the 36 months
of operating, you know, a window that, you know, everybody should have. They're not a very
on trying to hit, they blew it on trying to have their earnings per share go up by reducing the number
of shares in existence.
Shares, exactly.
So if you can't, if you can't, if you can't, earnings per share, you know, you take earnings,
you divide it by the number of shares.
So if earnings can't go up, just divide by the number of shares.
And earnings per share goes up.
Lower the number of shares.
Yeah.
If you had a million dollars from earnings, a million shares, it was a dollar per.
You get rid of half the shares.
It now goes up.
And so now, you know, you have CEO pay go through the roof.
but these companies are not any more resilient than they were before.
And so now they're in line for a bailout.
And I think a large caucus of people across both aisles are very clear that these things need to be wipeouts of the equity versus bailouts where, you know, folks who took advantage of the financial system here continue to get rewarded.
What do you guys think about that?
Totally agree.
If you wipe out the equity, though, just pausing for a second and taking the other side of the argument, I'm not saying this is the side of
I would take. If you wipe out the equity, would not some of the people who would hit that pain
are shareholders from a retirement home or a retirement plan, like CalPers may be owned. Pension funds,
yeah. Pension funds, et cetera. So, you know, it does seem like if you wipe out the equity,
you could have some unintended consequences of those equit holders. But I think what the other side
of the argument is we're going to have to have there be repercussions for people running companies
so close and recklessly to the cliff. And there has to be some pay. And there has to be some
not reward for doing that.
And a bailout is a reward for operating irresponsibly.
Is that what you're saying, Chamath?
Yeah, I think that actually you have to wipe out the equity.
And I think the reason why wiping out the equity is important is that it overwhelmingly does not punish the, you know, retiree in their who owns, you know, Boeing stock in their 401K.
Boeing has not been held by retirees in their full run case for years as a cohort of impactful investors.
Massive, large institutional pools of money own these companies.
These are the balance sheets of governments.
These are the balance sheets of foundations.
These are the balance sheets of a very few, very, very, very wealthy people.
And the reality is that for the broad-based population, for the 350-odd million Americans,
Americans in the United States, how many of them do you think are really active market participants?
Meaning for every dollar of value, creation, or destruction, how much do they actually see?
I would guess it's less than 10%, meaning 90 cents of every dollar are nameless, faceless
organizations in a financial infrastructure.
I think the lesson we have to tell and the place we have to move to is one of compassionate
at capitalism, which is that we have been so hell-bent on the use of leverage, on the use of
these financial gimmicks, on the use of accounting tricks to enrich a few at the sake of the many.
And this is the right time where you should nationalize some of these businesses.
And when they eventually do get taken back out and floated publicly, all of those proceeds
should go back to the United States Treasury, who should then use it to reinforce social
Security and Medicare and everything else because we are going to run a multi, multi-trillion
dollar budget deficit to get out of this.
And to just give people some context here, the U.S. national debt is at $23 trillion,
which is $72,000 per citizen and $109,000 for each citizen who pays taxes.
And we run our spending, our budget deficit is a billion, is a trillion dollars a year.
We're going to talk about here, I think, a two to three trillion dollar stimulus package,
which will increase the national debt load by only 10 percent.
So it does seem like we can manage that.
But boy, was this a strategic mistake for us to run up the debt during good times?
Was it not?
It's even simpler than this.
And I hate to say this so bluntly, but the Eurozone is going to collapse.
Okay.
Japan is finished.
So there are two economies that matter.
There's China and the United States as of today.
And the great thing about that is in a set of two,
there's only one instrument of safety,
which is the United States dollar.
Thank God.
In that world, the United States has exceptional leverage,
exceptional, exceptional leverage.
It is, and it has always been, you know,
the beacon, the light on the hill, et cetera.
Now, in a moment like this, the United States has the most ability to reset how we think about things.
It could run $5 trillion deficits tomorrow.
It could run $10 trillion deficits because it is still the backstop.
I'm not advocating for that.
But this is where I think you need bold, decisive action and not piecemeal strategies.
I don't think a trillion dollars is enough.
I really think that if you think about what the Eurozone will have to do and what's going to happen to the U.S. dollar,
we should be basically saying right off the bat at a minimum,
anyone who makes less than, you know, pick your number,
a million dollars a year,
every man, woman and child,
every or every 18-year-old American man and woman
should immediately get $5,000.
Forget $1,000, $2,000, $5,000.
And next month, if we're still out of business, $5,000.
And all of that does is just, it's a trillion dollars.
It's $2 trillion over two months.
And then you add another trillion dollars
and all this, you know, small business loans and all the other things, that's $3 trillion,
that you can deal with because we're the United States.
And I think it's really important to keep it in mind.
I know that sounds crazy.
Well, I mean, some people don't think, oh, you know, blah, blah, blah, you know, budgets and deficits.
But it's not because everybody else is just as fucked, if not more fuck.
Well, let me give you, let me give you another perspective.
The GDP of the United States is $20 trillion, roughly.
every month, let's assume the whole economy shuts down.
Every month that we're shut down costs us $1.5 trillion.
So if we're going to have the country shut down for, say, three months,
we're losing $4.5 trillion right there.
The problem is economic growth in the economy is actually a first order function, right?
So the movement of cash drives the future economy.
And so if we were just needing to fill that hole,
you would need to come up with a couple of trillion dollars,
and you would have the government going out
and buying ice cream cones and paying hair salons
and paying for dog walkers
and paying for construction workers
and paying for oil rig workers
and basically employing and buying all of those goods and services
for that functional equivalent of a $20 trillion GDP.
That's what it would take to just fill the hole.
Well, that's if you're assuming no economic activity.
I mean, we don't think there's going to be no economic activity.
maybe let's say it's a third less economic activity?
Jason, the shoe, guys, the shoe that hasn't dropped is this idea that everybody is at home working.
Nobody's at home working.
That's a joke.
That's a lie.
Okay?
Because as David said, companies are not, you know, self-contained units.
Very few are.
Many of them and most of them operate in a very interconnected, socially dependent way with other companies.
They're your customers.
You are their customers.
Nobody is doing anything right now.
There's nobody evaluating the next great SaaS tool.
Guys, come on.
And the other issue is just leverage, Jason, right?
So we've also got to remember that a big chunk of the economy is levered,
meaning that there's debt and debt payments that need to be paid.
And so those income streams are now going to be absent.
And so there's a multiplier effect.
When revenue goes down, the economic impact is actually multiplied.
And so you can't just fill the hole.
So it becomes a very complicated, nonlinear kind of system that you have to try and fill the holes.
And you've got to find the places where cash is missing and it's not moving the fastest.
And that's where you've got to throw the money in the first, like these repo markets and so on.
Well, and there's no doubt that we all agree, bottom up is the way to do this.
So if we have 330 million Americans, if you just have the bottom half get $1,000 a month,
that's call it $160 billion a month.
That's only over the year, $2 trillion.
So if we just did that, it gave everybody $1,000 a month, that's $12,000.
thousand dollars for the bottom half. They're not saving that money. They're going to use it.
They're going to spend it in the market, correct? They're going to pay their rent. They're going to go
get dinner. I don't think so. You think that poor people who are laid off right now are going to save the money?
Well, if you gave me a thousand dollars or, you know, somebody, a thousand dollars when they're in their house on the sixth week of their home confinement,
what you think they're like jumping? Well, I'm assuming that we're in week 10 and we're not in self-confinement anymore.
We agreed in the first third of the program that we're going to get there in whatever it is, 60 days.
90 days and we'll be back at work.
You know what I've realized after wearing the same pair of jeans four days in a row?
I have too many jeans.
That's what I've realized.
And you know what I've also realized that the cotton shirts that I buy from H&M are fucking
perfect.
And I've complicated my life with all kinds of bullshit that I've been buying because
I thought it meant something.
And right now it means absolutely jack shit.
Yeah.
I'd agree.
I'd agree with that perspective.
that's what's really interesting when you see your entire portfolio collapse when you see this belt tightening
it's happening even amongst and we have you know uh listen all three of us are lucky enough to be at the
you know in the top of our careers and top of our income at this point in our lives but we all came
from humble beginnings as well and if if the people at the top are belt tightening and saying you know what
I don't need to buy a $60 t-shirt I'm going to buy a $16 t-shirt boy does that have ramifications
across the entire economy
this reminds me very much of the recession.
They said luxury goods would never rebound,
and sure enough, the last 10 years,
luxury has rebounded massively.
Because it was not a psychological,
broad-based impact to people's philosophy
and framing of how they viewed the world.
You think so?
I don't have to the economic crisis last time.
People did say there would never be,
people specifically said there would never be luxury goods again,
and that it was the end of people buying that kind of shit.
I'm not talking about some prognosticating analysts.
You know,
only as, you know, good as their own biases.
What I'm saying is the average person didn't really have to internalize a broad-based
impact to their way in which they view what's important in their life.
This touches everybody.
And I think that there is an opportunity for us to really recalibrate what's important.
I think conspicuous consumption is unimportant.
You know, helping each other is important.
important. Taking, you know, unnecessary vacations because it drives your Instagram follower feed
is fucking stupid. Making sure that we can contribute the incremental dollar we have so that other
people could get tested and get back to work. That seems like a better use of your money and time.
Yeah. So. No, go ahead, David. Get in there. I think that there, yeah, there's just great
perspective setting that's happening. That's, that's happening. And it's going to.
going to happen broadly across the economy. We've been fat and happy for a long time.
And at least a sub-segment of the population has been. But we also have it really,
really, really good here in the United States. There's a website. I just recommend everyone
check out and spend some time on. It's called Dollar Street. And you can go to gapminder.org
slash dollar-dash street and check out the website. It is unbelievable. And it is probably my
favorite website on the internet. And Dollar Street is a project of Ola Roesling's wife.
Ola's the son of Hans Rosling, the great visual economist who told people stories with
visuals on like the world and income and population and growth and so on. And she went around
and she photographed families all over the world and showed how much money they make each month.
And then showed all these common household activities and goods brushing your teeth, the oven,
how do you, what kind of clothes do you have? What does your closet look like? What do you sleep on?
and it's pretty striking that half of the people don't have a toothbrush, a quarter of people use mud off the floor to brush their teeth.
Most people don't have a bed on planet Earth, right? Only the top 1% have a kitchen, right?
I mean, there's like these amazing statistics with photos that really help kind of illustrate this point.
And I think that I'm not saying that the extreme demonstration of humanity and the distribution of wealth, income, and prosperity in humanity is as relevant here.
But in all these photos, everyone's very happy and they live a happy life.
And there's a great reset happen that's happening that's underway.
Happiness eventually finds itself when the delta goes from being negative to being positive again.
When the delta is flat or the delta is negative, people are getting into a worse condition, things are bad.
So we're going to bottom out here.
And then we're going to, you know, no matter what state we find ourselves in, we'll very quickly find ourselves back in a state of happiness.
And we'll all reset with respect to Chimov's point on, hey, maybe I don't need all these genes.
Maybe I don't need all this and this and this.
but there's certainly like critical, you know, needs that people have,
and it's going to be pretty apparent pretty quickly,
you know, how the economy and people are going to adjust to this new world.
But there's going to be an adjustment.
The part of this that I think is actually constructive is,
I do think that we're going to swing the pendulum back towards nationalized economies
and away from global economies,
because I think this is a way that politicians all around the world,
they'll characterize it in different political language.
Some people will call it sort of like American exceptionalism if you're on the right.
If you're on the left, you'll describe it in much more social terms,
but they all lead to the same outcome, which is that what we have seen is that in the push
to globalization, we have created too much brittle infrastructure that doesn't work
and that we are not resilient enough.
men, we are hyper-efficient and we are just in time and all of that is great and everything is super cheap.
But when we really need infrastructure to work, whether it's tests or whether it's the government or what have you, it just doesn't.
And I think resiliency will force us to be more nationally attuned.
And I think it'll be the right thing.
It'll cause all governments to think about their own food supply differently, to think about their own supply chains differently.
It'll demand companies to be less profitable if it means that they can.
can withstand these kinds of shocks. And it's one thing to say that we could never have modeled,
you know, sort of like this two or three sigma event we're dealing with. But after the fact,
it's no longer a two or three sigma event. And governments have to now internalize this.
And companies have to internalize it. We are not going to act the same.
Borders will be different.
Look, think about the iPhone and obviously medicine and respirators. We've been talking about these things
over the last, you know, a couple of weeks as this happens.
If we do have a breakdown in relations with China,
if we, let's say we stop importing stuff,
what would happen to Apple,
the most powerful and valuable company?
How would they ever be able to make iPhones again in the United States?
Are they capable of making them?
No, it depends.
It depends on who you're answering it for.
On behalf of the U.S. customer,
Apple should probably be forced to bring a lot of their production capacity
back into the United States.
They should find the diversified global supply chains,
so that you have multiple suppliers in many countries in the world,
but they should rely more on America.
It will be less profitable, but it'll be okay and it's the right thing to do.
Yeah, it's $100.
What I read in the estimates was an iPhone would cost $100 or $100 and change more to make in the United States.
But if they did, they wouldn't have the supply chain issue.
They make $500, $600 per iPhone anyway.
Well, by the way, the real outcome is that, you know,
and we were going to do this anyways after this,
which is I don't think people are lining up to buy, you know,
kind of irrelevant products anymore in a way where we're just slavish to things.
I mean, I think it's important to ask ourselves, like, this is probably the most socially
impactful world event the globe has had to deal with since World War II.
And it's probably really important to talk to somebody you know.
And if you don't know, you can document and you can easily find the documents of people
who survive the Holocaust or live through the bombings in London, et cetera.
their mentality was different as a result of it.
It changed their behavior in very positive ways, right?
It was like the great advances in humanity happened after that.
It was being refocused.
Yeah, you're less focused on things that are not core or critically important.
And Freeberg, what do you think about what this is showing in the health care system
and the holes in the health care system.
The fact that we couldn't mobilize to deal with this after,
we did scenario planning about this after SARS.
We've done scenario planning.
We've had, you know, I sent to our group list,
the link of Bill Gates talking about this four or five years ago
and how this would be an issue.
I sent a couple of links to people writing about closing the wet markets in China
after the SARS outbreak.
I'm curious, David, what you'd think,
the holes in the healthcare system are that need to be fixed and what we can learn from this.
Because I think we're now coming into the, you know, as we got through the virus, we got
through the economic second order effects.
Let's talk about positively what we're going to learn because I think that's what Chmott's
getting at is that there's a personal recalibrating of what matters, maybe morality, ethics,
focus in our lives.
David, what can we learn from this on a health perspective?
What should we do when this ends?
There's no easy answer to that, right?
Nationalized healthcare systems, in some countries, you could say they're great.
My brother, my family lives in London.
I was talking to my brother yesterday.
And, you know, they tried to go down and get tested for a tooth infection yesterday.
And, like, it's just brutal dealing with NHS in the UK.
You know, people aren't telling great stories about NHS.
And they're not saying, oh, my God, it's the best health system.
I love it.
Healthcare is hard.
people want personalized care, they want a lot of attention.
There's only so many doctors.
There's only so much beds.
When you start giving people good care costs a lot.
Solving this stuff and the R&D dollars required to enter markets is so extraordinarily high,
you end up charging a lot for products and services on the back end.
It's a very complicated system and there's no simple answer.
I do think that we're learning and realizing pretty quickly that the U.S.,
and we're going to do some postmortems on this, obviously as a world, as a society.
One thing that's clear is the Chinese response, in part, was driven by a lack of bureaucratic red tape and an ability to manifest action and an ability to produce and distribute drugs and produce and distribute tests without needing approvals.
I think that's something that's going to change in the United States.
It has to.
The regulatory burden on health care companies, on pharmaceutical companies, on testing and diagnostics companies is extraordinarily high.
But the objective in the United States has been, do no harm, which means don't let anyone die.
through the action, but it may be that many people are dying through the inaction.
And I think we're going to maybe see a big shift in policy and allow right to try laws
that are going to be federalized. So, you know, states can make decisions about right to try
laws and doctors and patients can try drugs on their own discretion without having a federal
oversight body. Perhaps the same will happen with diagnostics and testing. And, you know,
with respect to what the, what services the government provides and doesn't provide, you know,
I'm not sure. There's a lot of data on either side here that nationalized health care systems do and don't work.
So it's very hard to say what the right solution is here. And I don't think that you want to try and take R&D and put it in the government. I think that's a terrible idea.
I think that there's a financial and a capitalistic motivation to find, discover molecules, get them tested and prove that they have a positive effect in human health.
And we need to move this towards personalized medicine, which actually changes the construct and probably include.
increases the cost of doing this about 10x.
We're already seeing this with stem cell therapies and CRISPR-based gene therapies,
is there so much more expensive.
In order to get that stuff moving faster,
we need to remove the regulatory burden and allow companies the ability to move quickly
and make this stuff more affordable.
The more barriers we put in front of companies, the harder it's going to be.
And if we try to do this with a top-down approach,
with the government deciding what to do R&D on and what not to do R&D on,
we're going to be in a fucking mess.
So those are some of my points.
Yeah, I would say as well, I think that there has to be, you know, after the great financial crisis, we smartened up about what the banks were allowed to do.
Unfortunately, we didn't really smarten up about what other financial participants were allowed to do.
And a lot of what we're seeing here is our excesses around leverage and credit.
And I think we need to fix those.
We need to tell companies that, you know, you can't put out certain amounts of debt.
We need to be a little draconian actually to reset this properly.
We need to tell, you know, market participants that you can't run 10 or 13 times levered.
You can't take $100 billion and make it act like $1.3 trillion and then blow a 50% hole in it.
You're just not allowed to do that.
I'm just sorry, but nobody should be allowed to do that.
Okay.
So if we look now onto politics, which is the least fun to talk about in many ways, but just on international relations, I think it's worth discussing.
There's been a bit of a debate about what we call this virus and the relationship between the United States and China.
China went on a little bit of a propaganda campaign in the last couple of days saying that the U.S. created the virus.
Trump has now been trolling them actively talking about the Chinese virus.
I used the other day, the Wuhan virus.
I didn't realize that people consider that racist to say Wuhan virus because we called it the Spanish flu and we called it the German measles.
But I guess people are particularly sensitive to this topic now.
And I think there's a critical issue here that I don't understand why we're not talking about this.
But wet markets specifically trade in exotic animals.
these viruses are contained in certain animals like bats, which are, you know, together in flocks of like thousands and the viruses.
And then these animals in wet markets, people don't know what that is.
You can Google it if you've got, if you're not squeamish.
But essentially in Chinese culture, as I've read it in the Wall Street Journal and in the World Health Organization's advisements to cancel and to shut down wet markets.
and there's unanimous agreement on this from the health officials that these have to be shut down.
The Chinese culture says we don't want to see meat in a package because we believe it's counterfeited and it's been frozen and it won't be as tasty and it won't have the same nutritional properties.
So you must slaughter the animal in front of us, at least for some significant percentage of the population.
there, it's a tradition, and this is where these viruses have uniformly been generated from.
And now we have the president and China going at each other.
And we have to have this very delicate conversation, I think, David, and I'm curious to your position on this,
because it's now hitting like a racial and, you know, and a bias against a certain culture
is how this is being framed by the left, which is just maddening because it's actually a culture,
it is a cultural issue that has to end, just like our cultural tradition of shape.
taking hands obviously needs to ends or be deprecated in some severe way.
So, David, maybe you could talk a little bit about what you think the outcome here is on a
political basis in relation to those wet markets and China and U.S. relationships.
Look, I think China suffered heavily.
I'm sure I've heard they're going to shut down the wet markets, but all I know is what
I've read on the Internet.
So, you know, I think they're fucking awful and stupid.
They should be shut down cultural, you know, dependence aside.
There's another issue in China.
Apparently, a huge amount of the impoverished communities in China are encouraged to actually grow and harvest rats.
I don't know if you guys are aware of this, but there's a bamboo rat business where you grow these rats inside of bamboo and then you kill them and you sell them.
And so the poorest people in China make money growing and selling rats, rat meat.
And the Chinese government just in the last week has told them to stop, which actually is a huge effect on many millions of families who are growing these rats.
So there's an economic effect, but it's obvious.
that it's a terrible health effect.
But I'm not sure that getting rid of the wet markets truly eliminates or eradicates the risk of a new viral outbreak, right?
Like, I think I mentioned to you guys on our text stream the other day, you know,
40% of the bacteria in the oceans are killed every day by viruses.
This is a great stat that Jennifer Dowdena uses in her book on the discovery of CRISPR.
And there's 10 to the 28th bacteria in the oceans.
So half of them, they all get killed every other day, every two days by viruses.
there are viruses everywhere.
They are going to emerge.
They are going to hit us.
The issue isn't necessarily where the source of the virus is coming from.
It's just that we have to have better testing and diagnostics and preparedness and treatment
plans and ability to motivate and mobilize ourselves to address pandemics like this in the future.
With respect to the relationship with China, I'm not an economist.
I'm not a trade guy.
I don't really know the nature of the relationships.
So I'll leave that to Chama.
No, my thought on this is that this is not a question of,
you know, wet markets or no wet markets. I think this is a question of if you are a,
um, an anchor participant of globalization in the global economy, is there an expectation
to have a common set of behaviors, the lowest common denominator set of behaviors and
hygines that everybody, uh, signs up for to be a, you know, fully fledged global market
participant. Now, the, the pros of that is that maybe everybody decides,
sides to be a participant and to have lax borders and, you know, free trade agreements that
there can be no wet markets and a whole host of other things. We all agree on, you know,
whether we are okay with shaking hands or maybe it's namaste from now on or maybe it's bowing.
The problem with that on the other side is that all of a sudden you create a monoculture that
strips away the individuality and the richness of every country. And, you know, I kind of think like,
like, you know, we could have attacked wet markets when HIV started to spread because it was, you know, as we understand it,
it was the emergence of the, you know, bushmeat and raw bushmeat and the killing of monkeys that had this virus that was then passed to humans, et cetera, et cetera, that that started the HIV epidemic.
So these things have happened before. And it's not as if we shut down, you know, all of those markets in Africa.
They still exist in some form or fashion. And as David said, there are huge economic ramifications to,
to having these cultural edicts.
And it's very difficult, I think,
for an American to demand China to do it
when we're not willing to step up,
just like in other ways, you know,
countries can demand us to lower our carbon emissions
and we say we're not going to do it.
So there are implications and very difficult issues
all over the place.
But I do think in general,
that if we move towards a more nationalistic,
economic,
dependency, interdependency, I think that it's probably the right thing to allow more
resilience to exist and for cultural diversity to continue to compound.
Because the world of just in time efficiency, I think we're learning now, was the wrong
optimization for the world.
we need to optimize for resiliency.
And that means some amount of inefficiency.
It means more mom and pop shops.
I think that that's a good thing.
It doesn't mean everything is Amazon Prime Now and Walmart.
I think that's okay.
It means that the iPhone is a little bit more expensive,
which means you upgrade every other year.
That's okay.
It means that companies like Google and Facebook and others
are less profitable in the short term.
That's also okay.
all of these things are okay.
We just need to decide, and now we need to move forward.
When do we, what's our best estimate of when people will be allowed to go to a restaurant?
I think it's, you know, again, getting back to what the people listening to this podcast probably care about most as we wrap up here in the second hour.
And thank you for tuning into the all-in podcast.
David Freembourg is with us from, what's the name of your incubator again?
David.
The production board.
The production board.
previously metramoclimate.com and Chamath Polyhapitia of Social Capital Partnership.
When do we suspect people will be allowed to go back to work in the Bay Area in New York?
When will people be able to go and have a meal in a restaurant?
Do you think this is May, June, or July or August?
When will we be out of quarantine?
I'm going crazy.
I'll give you my optimistic and then we can give the final word to David.
Here's my optimistic view.
Please.
I'm dying.
I think that the emerging evidence will soon be hard to ignore that we have a denominator
problem, which means that we're not testing enough, and that these IGG and IGM tests will
come online at scale in the next two weeks, and that we will establish demarc zones within
cities and towns, green zones, if you will, where people who are either negative or who have
already gotten and have tested positive for the antibodies will be allowed to interact. So I am telling
you that it's within six weeks from now. Six weeks from now, we'll be in restaurants,
and we may have to show our papers to somebody to get in or have our foreheads tested.
No, no, no, you just have to show your test result and have your passport or driver's license.
Yeah, I mean, I know this sounds crazy. I would much rather go to a
a restaurant in the next six weeks where I had to show my papers, a little bit tricony and sounds
a little dystopian. I would much rather go back to Tai Shokin and have my goddamn ramen
and show my papers and know everybody else did and then have everybody go through the, you know,
a very simple temperature test on their forehead like I give to my kids when they're sick.
David, you're taking the over or the under at six weeks for when we'll all be at
Ty Shokin having a ramen. I'm taking the under. I'm taking April 7th,
8th.
April 7th or 8th, and we're recording this, I think, on the 17th or the 18th, I think.
And so you're saying we're just going to be whatever 20 days out.
I too am taking the under, but barely.
I think it's, I think we're four or five weeks.
David, David, explain the undercase just so, and we can end on that.
But what's the under case?
Because that's a great note to end on.
Yeah.
So as we see the number, if you look at the UW virology website, and I've shared this
with people on my Twitter account, which I started doing yesterday, which is at Friedberg.
At Friedberg.
At Friedberg.
I'm not sure I'm going to stick with it.
I don't know if I have the stomach for it like you guys do.
But basically they're showing steady caseloads of positives per day, which again is delayed.
And if you look at the ICU availability in the emergency room wait time data, which I think are better leading indicators of where we are in the cycle.
New York is about two weeks behind us.
New York is going to be fucked for a little while.
But I do think that the West Coast and with some travel restrictions is going to be able to reopen for business, probably around.
April 7th or 8th, because we're going to see a dramatic decline at that point, and we're
going to see a lower fatality rate than everyone is predicting, and we're going to start to have
measures around washing your hands and masks, because you can't stay shut down for that long
without literally never being able to open again. So I'm kind of balancing the economic need
against what I think the data is starting to show that hopefully we are seeing the second
derivative turning negative now. And so we start to see a slowdown in new cases, and then we see a
a reduction in cases.
And I think that, you know,
there's a huge distribution
on what that model can tell you,
but I feel really good about,
like, April 7th or 8,
us getting enough confidence that,
okay, it's safe to go outside again.
And by the way,
if we don't open up for fucking business,
everyone's done forever.
All right.
So that's where I get the number.
And most importantly,
when do we feel comfortable playing cards again in person?
Because I'm starting to think that I want,
I know this sounds crazy,
but at this point,
if the three of us were positive and we'd gotten through it already, I would like to know that.
I think the entire poker group needs to get tested.
And the best possible scenario is that we're all inoculated.
We're not carriers anymore.
We're not carriers anymore. We're blockers in the system.
And we can get back to playing cards because I am, and I'm being a little facetious here,
but the chances are we might all have it, right?
I mean, it's a possibility.
I am going bonkers being at home.
I am not designed for social isolation.
I am going crazy.
Tomah, do you like it?
Yeah, I mean, I'm a pretty isolated person as a matter of course anyway, so other than work and, you know, my doing this or TV, I'm always at home.
Yeah.
And but the one thing that I cannot live without is Monday pokers.
And I'll really tell you why it's like in a moment like this, here's what I've realized.
I've realized just how much extraneous stuff I have in my life, how much I don't need it, how much I've occupied my time with things.
that are just not important.
And it's really allowed me to clarify, like, you know,
working on the next deal, not important.
Thinking about my status in society, not important.
Thinking about what other people think of me, not important.
My health, important.
My family and their health important.
And my friends, I love my friends.
Yeah.
We're very blessed.
I mean, I love the both of you.
that group saved me in some really tough moments in my life.
Yeah.
And I hate not seeing you guys and being able to, you know, just touch and feel you on once a week.
That to me is brutalizing.
And just to be clear, this is a poker group when we defy touching and feeling.
We're talking about poker chips.
We're making man love. It's fine.
We make man love over the poker table.
And that's how men commune is by just shifting large amounts of money across the table.
I miss you guys too. I'm going crazy.
I'm not going to be, I don't think like you're going to see me after this said and done.
I can't take seriously buying things.
I just think it's like, what the fuck is the point?
Yeah.
I really take seriously that we need to fix the social infrastructure of the United States
and in part do what we can to help as many people as possible.
All right.
They have the folks.
Chamoth Friedberg, 24.
Hey, Dave Freedberg.
Love you both.
Thanks a lot for doing this.
Chimoth, thanks a lot for doing this.
Follow at Chumath.
at Freedberg. If you want to help out the podcast, well, there's no ads to click on because
Chumath wants me to go broke on this. No ads, but I will say if you write us a five-star review
on iTunes, I guess that means we'll get indexed. And follow Friedberg, follow at Chimoth,
follow at Jason. We'll see you all next time. Bye-bye.
